Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dietary Ketosis a Metabolic Sister to Calorie Restriction (CR): Fatty Acids Activate AMPK Energy Circuits Modulating Global Methylation Via the SAM/SAH Axis

NCT03319173 is registered in ClinicalTrials.gov with Bristlecone Health, Inc. as lead sponsor.

NCT NCT03319173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03319173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dietary Ketosis a Metabolic Sister to Calorie Restriction (CR): Fatty Acids Activate AMPK Energy Circuits Modulating Global Methylation Via the SAM/SAH Axis
Lead sponsor
Bristlecone Health, Inc.
Phase
Not applicable
Overall status
Completed
Start date
October 15, 2017
Completion date
September 30, 2018
Enrollment
98 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome, mild cognitive impairment